A.S. Lok

416 total citations
19 papers, 298 citations indexed

About

A.S. Lok is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, A.S. Lok has authored 19 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in A.S. Lok's work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (6 papers). A.S. Lok is often cited by papers focused on Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (6 papers). A.S. Lok collaborates with scholars based in United States, Hong Kong and China. A.S. Lok's co-authors include Tak Mao Chan, Ching‐Lung Lai, Shiu‐Kum Lam, Matthew Ng, Frank J. Branicki, Wan Yee Lau, W. M. Hui, Jcm Ho, Ray Sánchez-Pescador and M S Urdea and has published in prestigious journals such as Hepatology, Journal of Hepatology and Nephrology Dialysis Transplantation.

In The Last Decade

A.S. Lok

19 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.S. Lok United States 9 194 188 78 44 27 19 298
Chuan‐Hao Lin United States 10 270 1.4× 261 1.4× 111 1.4× 59 1.3× 68 2.5× 15 476
Nasir Hassan Luck Pakistan 9 93 0.5× 118 0.6× 94 1.2× 49 1.1× 37 1.4× 65 266
Rekha Cheruvattath United States 7 234 1.2× 201 1.1× 166 2.1× 28 0.6× 49 1.8× 8 370
MF Yuen Hong Kong 11 201 1.0× 216 1.1× 133 1.7× 74 1.7× 47 1.7× 34 370
Jeffrey Weinstein United States 10 262 1.4× 229 1.2× 180 2.3× 57 1.3× 12 0.4× 18 357
Khurram Bari United States 13 342 1.8× 295 1.6× 183 2.3× 22 0.5× 27 1.0× 22 441
Khalid Al Kahtani Saudi Arabia 8 159 0.8× 153 0.8× 177 2.3× 38 0.9× 28 1.0× 13 287
Danny J. Avalos United States 9 84 0.4× 173 0.9× 88 1.1× 32 0.7× 52 1.9× 24 328
Andrew Kirk United Kingdom 5 200 1.0× 195 1.0× 126 1.6× 32 0.7× 37 1.4× 6 342
Sulleman Moreea United Kingdom 10 117 0.6× 123 0.7× 74 0.9× 44 1.0× 14 0.5× 24 233

Countries citing papers authored by A.S. Lok

Since Specialization
Citations

This map shows the geographic impact of A.S. Lok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.S. Lok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.S. Lok more than expected).

Fields of papers citing papers by A.S. Lok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.S. Lok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.S. Lok. The network helps show where A.S. Lok may publish in the future.

Co-authorship network of co-authors of A.S. Lok

This figure shows the co-authorship network connecting the top 25 collaborators of A.S. Lok. A scholar is included among the top collaborators of A.S. Lok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.S. Lok. A.S. Lok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Khalili, Mandana, Tania M. Welzel, Glen Lutchman, et al.. (2017). Safety and efficacy of velpatasvir and sofosbuvir with or without ribavirin for the treatment of HCV genotypes 1–6: results of the HCV-TARGET Study. Journal of Hepatology. 66(1). S716–S717. 3 indexed citations
3.
Sulkowski, Mark, K. Rama Reddy, David R. Nelson, et al.. (2017). Incidence of and predictors for direct acting antiviral treatment failure among 3909 hepatitis C genotype 1 infected adults: real world outcomes from HCV TARGET. Journal of Hepatology. 66(1). S719–S720. 1 indexed citations
4.
Lok, A.S., S. Locarnini, Fabien Zoulim, et al.. (2017). Durability of HBsAg loss with nucleotide analogs and pegylated interferon in patients infected with hepatitis B virus. Journal of Hepatology. 66(1). S264–S264. 1 indexed citations
5.
Läwitz, E., M. Rodríguez‐Torres, Tuyet Thi Nguyen, et al.. (2014). P1222 A PHASE II STUDY OF SAMATASVIR (IDX719) IN COMBINATION WITH SIMEPREVIR AND RIBAVIRIN IN TREATMENT-NAÏVE HCV-INFECTED SUBJECTS WITH GENOTYPES 1B AND 4 (HELIX-1 STUDY). Journal of Hepatology. 60(1). S495–S496. 7 indexed citations
6.
7.
Rao, Huiying, et al.. (2011). 1339 IL28B GENETIC VARIANTS AND GENDER ARE ASSOCIATED WITH SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS INFECTION. Journal of Hepatology. 54. S529–S529. 2 indexed citations
8.
9.
Николаева, Ольга Викторовна, Laura Steel, Claus J. Fimmel, et al.. (2003). 1261 GP73, a resident golgi membrane protein, appears in sera of patients with viral liver disease and hepatocellular cancer. Hepatology. 38. 768–768. 3 indexed citations
10.
Andreoné, Pietro, Maurizio Biselli, A.S. Lok, et al.. (2001). Outcome of patients with HBeAG negative hepatitis B awaiting liver transplantation (OLT) treated with lamivudine. Journal of Hepatology. 34. 31–31. 1 indexed citations
11.
Chan, Ta‐Chien, et al.. (1998). Hepatitis C virus genotypes in patients on renal replacement therapy. Nephrology Dialysis Transplantation. 13(3). 731–734. 11 indexed citations
12.
Ghany, Marc G., Tak Mao Chan, Ray Sánchez-Pescador, M S Urdea, & A.S. Lok. (1996). Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection. Digestive Diseases and Sciences. 41(11). 2213–2218. 20 indexed citations
13.
Chan, Tak Mao, et al.. (1996). Efficacy and side-effects of interferon in the eradication of chronic hepatitis C virus infection in hemodialysis patients. The HKU Scholars Hub (University of Hong Kong). 1 indexed citations
14.
15.
16.
17.
Hui, W. M., Shiu‐Kum Lam, Jcm Ho, et al.. (1991). Effect of omeprazole on duodenal ulcer-associated antral gastritis andHelicobacter pylori. Digestive Diseases and Sciences. 36(5). 577–582. 75 indexed citations
18.
Chan, Tak Mao, et al.. (1991). Hepatitis C Infection Among Dialysis Patients: A Comparison Between Patients on Maintenance Haemodialysis and Continuous Ambulatory Peritoneal Dialysis. Nephrology Dialysis Transplantation. 6(12). 944–947. 50 indexed citations
19.
Hc, Thomas, I V Weller, A.S. Lok, & Sheila Sherlock. (1983). ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS-B VIRUS-INFECTION. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuan‐Hao Lin Breakdown of academic impact, for papers by Nasir Hassan Luck Breakdown of academic impact, for papers by Rekha Cheruvattath Breakdown of academic impact, for papers by MF Yuen Breakdown of academic impact, for papers by Jeffrey Weinstein Breakdown of academic impact, for papers by Khurram Bari Breakdown of academic impact, for papers by Khalid Al Kahtani Breakdown of academic impact, for papers by Danny J. Avalos Breakdown of academic impact, for papers by Andrew Kirk Breakdown of academic impact, for papers by Sulleman Moreea
Rankless by CCL
2026